Skin Deep

MidState Skin Institute incorporates new technology to change the way non-melanoma skin cancers are treated.

Living in the Sunshine State, Florida residents know the damage that the sun can do to their skin, and they have to stay on top of their skin care. Skin cancer a ects 6 million people per year and costs an average of $8 billion per year. A variety of treatments are available, but Ocala’s own Dr. Ashley Cauthen of MidState Skin Institute is bringing game-changing technology to her Central Florida practice. This new treatment option o ers a painless, safe, and, best of all, e ective way to treat non-melanoma skin cancers. Treatments take only a few minutes. This technique will ease the process of removing cancer cells with no healing or down time required.

Meet The SRT-100

This technology is called the SRT-100™, which stands for Superficial Radiation Therapy. This technique uses a low-dose of superficial radiation therapy that penetrates only skin deep to zap cells that cause basal and squamous cell carcinoma—the two most common types of skin cancer. The radiation also destroys non-malignant tumor cells that cause keloids, which are scar-like in appearance.

Sensus Healthcare CEO Joseph Sardano explains, “Other modes of radiation are not the best way to treat skin cancer because of the radiation dose and because of how sensitive the skin is. Our system only penetrates 5 millimeters below the surface of the skin,

Dermatologists and healthcare providers are able to use the SRT-100™ in-o ce without having a radiation oncologist or medical physicist present to oversee the process. Patients diagnosed with basal or squamous cell carcinomas can then be conveniently treated right in their physician’s o ce. These skin cancers are superficial, and the SRT-100™ is gentle enough to be painless, but strong enough to be e ective at ridding the cancerous cells from the body.

Sensus Healthcare is a South Florida medical technology company that supplies healthcare providers with this equipment, and has distributed the SRT-100™ to providers all over the world. For many years, the Mohs surgical procedure has been required to rid basal and squamous cell carcinomas. This procedure requires cutting, potential scarring, and a more involved healing process. More than that, the Mohs procedure has been the most prevalent way to treat superficial skin cancers or irregularities—until now.

With the SRT-100™, patients don’t have to worry about cutting, bleeding, stitching, or scarring. There is no need for anesthesia and no recovery downtime. The low-dose radiation used to destroy the cancerous cells does not harm any surrounding or underlying tissues, resulting in a better cosmetic outcome. This treatment is also ideal for seniors who may experience slower healing times when it comes to surgeries or who are just not good surgical candidates.

Because of Sensus Healthcare’s innovative treatment technology, it won the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award in September, scoring 9.5 out of 10 possible points on the Frost & Sullivan scorecard.

“This award highlights the transformation Sensus has undergone in recent years as well as the acceptance we have achieved with physicians and patients,” says Sardano. “The Frost & Sullivan award not only validates our technology, but supports our e orts to increase the awareness of our unique technology solution to e ectively address an important niche of the cancer treatment market.”

Sensus Healthcare

851 Broken Sound Parkway, Boca Raton (561) 922-2071 sensushealthcare.com

More Options At MidState Skin Institute

Sensus Healthcare’s equipment is ideal for private dermatology and oncology practices, hospitals, and other health care providers. Dr. Ashley Cauthen of MidState Skin Institute explains that dermatologists have been using radiation to treat patients for over 50 years.

“We had previously gotten away from this technique because the technology was not keeping up with changing times,” she says. “However, Sensus has brought to market a great device that is safe and e ective at treating non-melanoma skin cancers.”

While surgery still remains the gold standard when appropriate, Cauthen has many patients who are tired of getting cut on and don’t want the downtime or scars associated with surgery. She is looking forward to providing her patients with more options for treating their skin cancers. For example, she says the SRT-100™ will be a great option for skin cancers on the legs of golfers or for skin cancers on the nose where surgery could be disfiguring. Cure rates are comparable to surgery at and above 96 percent.

MidState Skin has the machine already and is in the process of completing training and calibration.

“It is exciting to o er patients a ‘scarless’ technique,” says Cauthen. “We hope to treat our first patient in June.”

MidState Skin Institute Services

CLINICAL DERMATOLOGY:

› Acne

› Eczema

› Psoriasis

› Skin Cancer

› Vitiligo

› Sun Spots

› Liver Spots

› Rosacea

›

COSMETIC DERMATOLOGY:

› Botox

› Fillers (Juvederm/Restylane)

› Laser hair removal

› Photofacials for rosacea & sun damaged skin

› Laser treatments for acne scarring

› Individualized skin care regimens

› VelaShape cellulite reduction treatment